Log in with your email address username.


[Comment] Sickle cell disease: tipping the balance of genomic research to catalyse discoveries in Africa

The completion of the Human Genome Project and the use of CRISPR/Cas9 for gene editing have begun to transform the diagnosis and management of disease. Sickle cell disease has been considered a perfect model for genomic research because it is a monogenic disease that is common and causes substantial morbidity and mortality but has no cure. The recent use of gene editing to modify disease severity1 and a case report of a patient with sickle cell disease who received successful treatment with gene therapy2 highlight the potential for translating genome-based knowledge into health benefits.